XenTech
Genopole – Campus 3
4 rue Pierre Fontaine
91000 Evry
FRANCE
www.xentech.eu
Team members working on ITCC-P4 with their position and email address
- Emilie INDERSIE - R&D Projects Manager – emilie.indersie@Xentech.eu
- Jean-Gabriel JUDDE – President and Chief Scientific Officer – jgjudde@Xentech.eu
Company presentation
XenTech is an innovative research-based company dedicated to cancer biomarkers and translational research in oncology, which offers preclinical services to evaluate the anti-cancer potential of drug candidates.
With the view to developing novel approaches to anti-cancer therapies discovery, XenTech maintains a large panel of human tumorgrafts directly established from patients, representing the major solid tumor types (breast, colon, lung and prostate) as well as other less common malignancies (ovary, brain, pancreatic and soft tissue tumors).
This pre-clinical platform is made available to Pharmaceutical Companies and Academic Institutions through contract research services and scientific collaborations, giving access to XenTech’s xenograft models, their molecular characterization and drug response data.